Kezar Life Sciences, Inc. (KZR) Reports Q2 Loss of $0.30/sh

Kezar Life Sciences, Inc. (NASDAQ: KZR) reported Q2 EPS of ($0.30), versus ($0.34) reported last year.

For earnings history and earnings-related data on Kezar Life Sciences, Inc. (KZR) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Aon plc (AON) files mixed shelf
• Trump plans to pursue removal of Fed Governor Lisa Cook after court ruling - CNBC interview